Selective modulation of protein kinase A and protein kinase C activities in epidermal growth factor (EGF)-stimulated MCF-7 breast cancer cells

被引:15
|
作者
Mueller, H
Liu, R
David, F
Eppenberger, U
机构
[1] UNIV BASEL HOSP, SCH MED, DEPT RES, CH-4031 BASEL, SWITZERLAND
[2] STIFTUNG TUMORBANK BASEL, CH-4031 BASEL, SWITZERLAND
关键词
breast cancer; cell proliferation; protein kinase A; Protein kinase C;
D O I
10.1515/bchm.1997.378.9.1023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In human MCF-I breast cancer cells, both protein kinase A (PKA) and different members of the protein kinase C (PKC) family are stimulated upon binding of epidermal growth factor (EGF) to cell surface receptors. Selective stimulation of calcium-dependent PKCs with 10(-6) to 10(-9)M Thymeleatoxin significantly increased the proliferation rate of MCF-7 cells over 5 days in culture. This stimulation was blocked by the PKC antagonist Chelerythrine. In contrast, selective activation of PKA by addition of 1 mM dibutyryl cyclic AMP (dBcAMP) did not affect the proliferation rate of MCF-7 cells. Similarly, activation of the adenylate cyclase by 1 mu M Forskolin and inhibition of PKA by the cyclic AMP analogue Rp-cAMPS did not modulate the proliferation rate of these cells. Activation of PKC stimulated the expression of the immediate early gene c-fos but c-myc expression was not significantly enhanced. On the other hand, PKA activation increased both c-myc and c-fos expression in MCF-7 cells. These results suggest that PKA activation and c-myc expression are not obligatory for proliferation of MCF-7 cells.
引用
收藏
页码:1023 / 1029
页数:7
相关论文
共 50 条
  • [41] Protein Kinase C In Breast Cancer Downstream Of Growth Factor And Adhesion Signalling
    McCumiskey, M.
    Dowling, C.
    Dwane, S.
    Merrigan, A.
    Lal, A.
    Tormey, S.
    Murphy, M.
    Kelly, E.
    Dalton, T.
    Kiely, P. A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S397 - S397
  • [42] Progestin and G protein-coupled receptor 30 inhibit mitogen-activated protein kinase activity in MCF-7 breast cancer cells
    Ahola, TM
    Alkio, N
    Manninen, T
    Ylikomi, T
    ENDOCRINOLOGY, 2002, 143 (12) : 4620 - 4626
  • [43] Correlation of protein kinase A and protein kinase C activities in normal breast tissue
    Gordge, PC
    Hulme, MJ
    Clegg, RA
    Miller, WR
    BREAST, 1998, 7 (01): : 49 - 54
  • [44] Heparin induced apoptosis of breast cancer cells is associated with modulation of endogenous Protein Kinase C (PKC) activities
    Chen, Y.
    Scully, M.
    Ajay, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 462 - 462
  • [45] EFFECT OF ETHANOL ON PROTEIN-KINASE-C ACTIVATION AND REGULATION OF EPIDERMAL GROWTH-FACTOR (EGF) ENDOCYTOSIS
    BASKIN, G
    KUSHWAHA, A
    SCHENKER, S
    HENDERSON, GI
    HEPATOLOGY, 1990, 12 (04) : 922 - 922
  • [46] PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?
    Maioli, E
    Fortino, V
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1293 - 1294
  • [47] PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?
    E Maioli
    V Fortino
    British Journal of Cancer, 2004, 90 : 1293 - 1294
  • [48] Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells
    Song, Robert X. -D.
    Zhang, Zhenguo
    Chen, Yucai
    Bao, Yongde
    Santen, Richard J.
    ENDOCRINOLOGY, 2007, 148 (08) : 4091 - 4101
  • [49] Protein kinase C-α mediates epidermal growth factor receptor transactivation in human prostate cancer cells
    Stewart, JR
    O'Brian, CA
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (05) : 726 - 732
  • [50] Differences in protein kinase C and estrogen receptor α, β expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants
    Burow, ME
    Weldon, CB
    Chiang, TC
    Tang, Y
    Collins-Burow, BM
    Rolfe, K
    Li, SF
    McLachlan, JA
    Beckman, BS
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (06) : 1179 - 1187